Bruker Announces Majority Investment in Mimetas To Advance Human Physiology-Relevant Drug Discovery And Development
BRKR•Bruker announces majority investment in Mimetas
Aug. 10 (Reuters) - Bruker Corporation BRKR.O:
- Bruker announces majority investment in MIMETAS to advance human physiology-relevant drug discovery and development.
- Bruker Corporation said financial details were not disclosed; MIMETAS will operate under its existing brand and management.
- Bruker Corporation said MIMETAS provides scalable organ-on-a-chip solutions for human-relevant tissues.
